Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Cascadian Therapeutics Inc.
Scientific Title
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma